# KARYOPHARM THERAPEUTICS INC (KPTI)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/KPTI/

- Reporting holders: 2
- Reported value: $1.1K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $1.1K | 865 | 0.0% | 1 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $81 | 66 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 2 | $1.1K |
| Q2 2026 | 102 | $235.7M |
| Q1 2026 | 85 | $150.0M |
| Q4 2025 | 70 | $84.5M |
| Q3 2025 | 56 | $40.5M |
| Q2 2025 | 51 | $20.7M |
| Q1 2025 | 50 | $199.9M |
| Q4 2024 | 2 | $67.1K |
| Q3 2024 | 2 | $715.7K |
| Q2 2024 | 2 | $759.5K |
| Q1 2024 | 2 | $126.4K |
| Q4 2023 | 2 | $98.5K |